CSC-CAMS/PUMC-Oxford High level Innovative Talent Programme
This high-level medical innovative talent training programme, supported by the China Scholarship Council, Chinese Academy of Medical Sciences & Peking Union Medical College and the University of Oxford, which is referred to as the MD/PHD Scholarship Programme, is aimed at cultivating talented students to be interdisciplinary and innovative clinicians/scientists.
COI prioritise funding support to the current crisis caused by novel coronavirus
Tao Dong's group publish new research on Self-maintaining CD103+ cancer-specific T cells
Latest News
COVID Without Borders - A collaboration to Investigate A New Disease
21 July 2020
On the morning of 1st July 2020, the webinar “COVID Without Borders – A collaboration to Investigate A New Disease” was held online. It was jointly organised by the Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College and CAMS-Oxford Institute (COI).
COI prioritise funding support to the current crisis caused by novel coronavirus
6 February 2020
The CAMS Oxford Institute has prioritised funding support in response to the current crisis caused by nCoV 2019, supporting positive actions taken by the Medical Sciences Divisions and University of Oxford.
Chinese Scholarship Council (CSC) - NDM - CAMS Oxford Institute (COI) Scholarship Interviews 2019
2 December 2019
The CSC-CAMS/PUMC Oxford High-level Innovative Talent Scholarships and CSC-NDM Scholarships Interviews were held in Beijing in November 2019, representatives from the University of Oxford, the Chinese Academy of Medical Sciences (CAMS) and the Chinese Scholarship Council (CSC) were present.
Tao Dong's group publish new research on Self-maintaining CD103+ cancer-specific T cells
28 November 2019
A new research discovered circulating antigen-specific CD103+CD8+ T cells can self-regulate their CD103 expression via production of active TGFβ1 and have better TCR signalling and effector function compared to CD103- populations.
Latest publications
-
Erratum: Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike (Cell Host & Microbe (2020) 28(3) (445–454.e6), (S1931312820303516), (10.1016/j.chom.2020.06.010))
Journal article
Huo J. et al, (2020), Cell Host and Microbe, 28
-
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
Journal article
Knight SR. et al, (2020), BMJ, m3339 - m3339
-
Autoantibody-dependent amplification of inflammation in SLE.
Journal article
Lou H. et al, (2020), Cell death & disease, 11
-
Assembly intermediates of orthoreovirus captured in the cell.
Journal article
Sutton G. et al, (2020), Nature communications, 11
-
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
Journal article
Peng Y. et al, (2020), Nature immunology